↓ Skip to main content

Cochrane Database of Systematic Reviews

Zonisamide for neuropathic pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
14 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
133 Mendeley
Title
Zonisamide for neuropathic pain in adults
Published in
Cochrane database of systematic reviews, January 2015
DOI 10.1002/14651858.cd011241.pub2
Pubmed ID
Authors

R Andrew Moore, Philip J Wiffen, Sheena Derry, Michael PT Lunn

Abstract

Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. The efficacy of zonisamide for the relief of neuropathic pain has not previously been reviewed.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 132 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 17%
Student > Bachelor 18 14%
Other 11 8%
Student > Ph. D. Student 9 7%
Student > Doctoral Student 8 6%
Other 22 17%
Unknown 42 32%
Readers by discipline Count As %
Medicine and Dentistry 48 36%
Nursing and Health Professions 15 11%
Social Sciences 5 4%
Computer Science 3 2%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 14 11%
Unknown 45 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2019.
All research outputs
#2,724,966
of 23,398,349 outputs
Outputs from Cochrane database of systematic reviews
#5,504
of 12,684 outputs
Outputs of similar age
#39,863
of 354,834 outputs
Outputs of similar age from Cochrane database of systematic reviews
#127
of 290 outputs
Altmetric has tracked 23,398,349 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,684 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.0. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 290 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.